it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done...

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

worried about how helen was doing after doctors performed surgery on her colon the same day he was admitted, robert, whose condition stabilized, had a simple request for his nurse:.

meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world..